Key facts
- This page summarizes Edward L. Kuntz's Form 4 filing for U S PHYSICAL THERAPY INC /NV (USPH).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 16 May 2024, 17:14.
Edward L. Kuntz - 15 May 2024 Form 4 Insider Report for U S PHYSICAL THERAPY INC /NV (USPH)
- Reporting relationship
- Director
- Issuer ticker
- USPH
- Reported as of
- 15 May 2024
- Net transaction value
- -$268,925
- SEC form
- 4
- Accepted by SEC
- 16 May 2024, 17:14:01 UTC
- Prior SEC filing
- 05 Mar 2024
- Next SEC filing
- 28 Feb 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Edward Kuntz
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Edward L. Kuntz filed Form 4 for U S PHYSICAL THERAPY INC /NV (USPH) on 16 May 2024.
Change
- Previous filing in this sequence was filed on 05 Mar 2024.
- Current net transaction value: -$268,925.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
USPH
transaction
Common Stock
Sale
- Transaction value
- $268,925
- Shares
- -2,500
- Change %
- -43%
- Price
- $107.57
- Shares after
- 3,280
- Date
- 15 May 2024
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The price reported ($107.57) is the weighted average price. The shares were sold in multiple transactions at prices ranging from $107.15 to $108.09 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.